Clinical trial
A Prospective Study of Testosterone Supplementation in Hypogonadal Patients Receiving a Renal Transplant
NCT07287800 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study of Testosterone Supplementation in Hypogonadal Patients Receiving a Renal Transplant
- Lead sponsor
- University of California, Los Angeles
- Phase
- Phase 1/2
- Overall status
- Active, not recruiting
- Start date
- July 1, 2025
- Completion date
- June 30, 2027
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease (esrd), hypogonadism, male, kidney transplant